Literature DB >> 29268082

Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.

Bianca Schulte1, Anastasia Selyutina1, Silvana Opp1, Alon Herschhorn2, Joseph G Sodroski2, Massimo Pizzato3, Felipe Diaz-Griffero4.   

Abstract

SERINC5(S5) is a multi-span transmembrane protein that potently blocks the infectivity of HIV-1 produced by human T-cells. The ability of S5 to restrict infectivity correlates with its presence in the virion, but the exact mechanism by which S5 restricts HIV-1 is unknown. Here we tested whether the core from HIV-1 virions containing S5 is delivered to the cytoplasm. Using the "fate of the capsid" assay, we demonstrated that the viral core of S5-restricted HIV-1 does not reach the cytoplasm of target cells, suggesting a block in the delivery of the core to the cytoplasm. In agreement with evidence suggesting that the viral determinants for S5 restriction map to the envelope of HIV-1, we observed that S5 induces conformational changes to the HIV-1 envelope. Further, we demonstrated that S5 localizes to detergent-resistant membranes (DRMs), as has been shown previously for the HIV-1 envelope in producer cells. In order to identify the determinants of S5 restriction, we explored the ability of all human SERINC proteins to restrict HIV-1. In contrast to human S5, we observed that human SERINC2(S2) did not restrict HIV-1, and was inefficiently incorporated into HIV-1 virions when compared to S5. Experiments using S5-S2 chimeric proteins revealed two functional domains for restriction: one necessary for S5 incorporation into virions, which does not seem to be necessary for restriction, and a second one necessary to change the HIV-1 envelope conformation, localize to DRMs, and block infection.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Core; DRMs; Envelope; HIV-1; Restriction; SERINC2; SERINC5

Mesh:

Substances:

Year:  2017        PMID: 29268082      PMCID: PMC5801005          DOI: 10.1016/j.virol.2017.12.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  26 in total

1.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.

Authors:  D H Nguyen; J E Hildreth
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Detergent resistance as a tool in membrane research.

Authors:  Daniel Lingwood; Kai Simons
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

4.  The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.

Authors:  Anke Heigele; Dorota Kmiec; Kerstin Regensburger; Simon Langer; Lukas Peiffer; Christina M Stürzel; Daniel Sauter; Martine Peeters; Massimo Pizzato; Gerald H Learn; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2016-09-14       Impact factor: 21.023

5.  Serinc, an activity-regulated protein family, incorporates serine into membrane lipid synthesis.

Authors:  Madoka Inuzuka; Minako Hayakawa; Tatsuya Ingi
Journal:  J Biol Chem       Date:  2005-08-24       Impact factor: 5.157

6.  Cellular uptake of avian leukosis virus subgroup B is mediated by clathrin.

Authors:  Felipe Diaz-Griffero; Antony P Jackson; Jürgen Brojatsch
Journal:  Virology       Date:  2005-06-20       Impact factor: 3.616

7.  Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles.

Authors:  Jayanta Bhattacharya; Paul J Peters; Paul R Clapham
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.

Authors:  Rachel P J Lai; Jin Yan; Jonathan Heeney; Myra O McClure; Heinrich Göttlinger; Jeremy Luban; Massimo Pizzato
Journal:  PLoS Pathog       Date:  2011-12-15       Impact factor: 6.823

9.  SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.

Authors:  Yoshiko Usami; Yuanfei Wu; Heinrich G Göttlinger
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

10.  A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry.

Authors:  Alon Herschhorn; Christopher Gu; Nicole Espy; Jonathan Richard; Andrés Finzi; Joseph G Sodroski
Journal:  Nat Chem Biol       Date:  2014-08-31       Impact factor: 15.040

View more
  21 in total

1.  SERINC5 Inhibits HIV-1 Infectivity by Altering the Conformation of gp120 on HIV-1 Particles.

Authors:  Austin Featherstone; Christopher Aiken
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

2.  Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5.

Authors:  Isabelle Staropoli; Jérémy Dufloo; Olivier Schwartz; Nicoletta Casartelli; Anaïs Ducher; Pierre-Henri Commere; Anna Sartori-Rupp; Sophie Novault; Timothée Bruel; Valérie Lorin; Hugo Mouquet
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

3.  An N-Glycosylated Form of SERINC5 Is Specifically Incorporated into HIV-1 Virions.

Authors:  Shilpi Sharma; Mary K Lewinski; John Guatelli
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

Review 4.  Multifaceted Roles of TIM-Family Proteins in Virus-Host Interactions.

Authors:  John P Evans; Shan-Lu Liu
Journal:  Trends Microbiol       Date:  2019-11-12       Impact factor: 17.079

5.  HIV-cell membrane fusion intermediates are restricted by Serincs as revealed by cryo-electron and TIRF microscopy.

Authors:  Amanda E Ward; Volker Kiessling; Owen Pornillos; Judith M White; Barbie K Ganser-Pornillos; Lukas K Tamm
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

6.  Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters.

Authors:  Yen-Cheng Chen; Chetan Sood; Mariana Marin; Jesse Aaron; Enrico Gratton; Khalid Salaita; Gregory B Melikyan
Journal:  ACS Nano       Date:  2020-06-01       Impact factor: 15.881

7.  SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.

Authors:  Yue Liu; Hong Wang; Jun Zhang; Jing Yang; Lu Bai; Baisong Zheng; Tianhang Zheng; Yingchao Wang; Jianhua Li; Wenyan Zhang
Journal:  Front Microbiol       Date:  2020-04-30       Impact factor: 5.640

8.  SERINC5 Potently Restricts Retrovirus Infection In Vivo.

Authors:  Uddhav Timilsina; Supawadee Umthong; Brian Lynch; Aimee Stablewski; Spyridon Stavrou
Journal:  mBio       Date:  2020-07-14       Impact factor: 7.867

Review 9.  Plasma Membrane-Associated Restriction Factors and Their Counteraction by HIV-1 Accessory Proteins.

Authors:  Peter W Ramirez; Shilpi Sharma; Rajendra Singh; Charlotte A Stoneham; Thomas Vollbrecht; John Guatelli
Journal:  Cells       Date:  2019-09-02       Impact factor: 6.600

10.  Coelacanth SERINC2 Inhibits HIV-1 Infectivity and Is Counteracted by Envelope Glycoprotein from Foamy Virus.

Authors:  Pavitra Ramdas; Vipin Bhardwaj; Aman Singh; Nagarjun Vijay; Ajit Chande
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.